Sustainable Provision of Generic Medicines in Europe
نویسنده
چکیده
منابع مشابه
The Availability and Affordability of Cardiovascular Medicines for secondary prevention in Tehran Province
Abstract Abstract Background: Availability and affordability of medicines are crucial to achieving success in prevention programs, particularly in developing countries. Objective: The aim of this study was to determine the availability and affordability of cardiovascular medicines for secondary prevention in Tehran province of Iran. Methods: A cross-sectional survey was conducted in Tehran pro...
متن کاملThe Availability and Affordability of Cardiovascular Medicines for secondary prevention in Tehran Province
Abstract Abstract Background: Availability and affordability of medicines are crucial to achieving success in prevention programs, particularly in developing countries. Objective: The aim of this study was to determine the availability and affordability of cardiovascular medicines for secondary prevention in Tehran province of Iran. Methods: A cross-sectional survey was conducted in Tehran pro...
متن کاملDeveloping competitive and sustainable Polish generic medicines market.
AIM To descriptively analyze the policy environment surrounding the Polish generic medicines retail market. METHOD The policy analysis was based on an international literature review. Also, a simulation exercise was carried out to compute potential savings from substituting generic for originator medicines in Poland using IMS Health pharmaceutical intelligence data. RESULTS Poland has a mat...
متن کاملGeneric Medicine Pricing Policies in Europe: Current Status and Impact
Generic medicine pricing is an area of national responsibility of European Union countries. This article aims to present the current status and impact of generic medicine pricing policies in ambulatory care in Europe. The study conducts a literature review of policies relating to free-pricing systems, price-regulated systems, price differentiation, price competition and discounts, and tendering...
متن کاملBiosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines
For many years European governments have sought to ensure a high degree of competition in off-patent pharmaceutical markets in order to generate price competition and consequently benefits such as improved patient access or savings for payers after patent expiry. The pharmaceutical industry believes that access to valuable new treatments and post-exclusivity competition are essential for the su...
متن کامل